Sanofi将其风险基金增加到14亿美元,以支持生物技术和数字保健新创办企业。 Sanofi boosts its venture fund to $1.4 billion to back biotech and digital health startups.

Sanofi为其风险资本部门Sanofi Ventures增加了6.25亿美元,将其管理下的资产总额增加到14亿美元。 Sanofi has added $625 million to its venture capital arm, Sanofi Ventures, raising its total assets under management to $1.4 billion. 这笔资金将支助生物技术、数字保健以及免疫学、神经学和罕见疾病等相关领域的早期和成长阶段初创企业。 The funding will support early- and growth-stage startups in biotechnology, digital health, and related fields like immunology, neurology, and rare diseases. 投资凸显了Sanofi通过伙伴关系推动医疗创新的战略,不仅为创业提供资本,而且提供战略指导。 The investment underscores Sanofi’s strategy to drive medical innovation through partnerships, offering startups not only capital but strategic guidance. 自2012年以来,该基金支持了70多个公司,最近的出口总额达32.5亿美元。 The fund has backed over 70 companies since 2012, with recent exits totaling $3.25 billion. Sanofi Ventures继续在风险资本市场收紧的情况下带头或共同带头进行回合,2025年关闭了11项交易,预计会有新的投资。 Sanofi Ventures continues to lead or co-lead rounds amid tighter venture capital markets, with 11 deals closed in 2025 and new investments expected.